Panacea Biotec Ltd

📊 Panacea Biotec Board to Review Q3 & 9M FY2026 Results on Feb 11

• Board Meeting scheduled for February 11, 2026, in New Delhi.

• Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2025 will be considered and approved.

• Trading window for all Designated Persons (and their immediate relatives) remains closed until February 13, 2026.